Zhiqiang Feng

Zhiqiang Feng


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ZFZhiqiang Feng
Zhiqiang Feng
XLXingzhou Li
Xingzhou Li
GZGuojun Zheng
Guojun Zheng
LHLiang Huang
Liang Huang


4 March 2022 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
FLFangfang Lai
Fangfang Lai
MJMing Ji
Ming Ji
LHLei Huang
Lei Huang
YWYunchen Wang
Yunchen Wang
NXNina Xue
Nina Xue
XCXiaoguang Chen
Xiaoguang Chen
PD-1 and PD-L1 antibodies have brought about extraordinary clinical benefits for cancer patients, and their indications are expanding incessantly. Currently, most PD-1/PD-L1 agents are administered intravenously, which may be uncomfortable for some cancer patients. Herein, we develop a novel oral-delivered small molecular, YPD-29B, which specifically targets human PD-L1. Our data suggested that YPD-29B could potently and selectively block the interaction between PD-L1 and PD-1, but did not inhibit any other immune checkpoints. Mechanistically, YPD-29B induced human PD-L1 dimerization and internalization, which subsequently activated T lymphocytes and therefore overcomes immunity tolerance in vitro. YDP-29B was modified as the YPD-30 prodrug to improve druggability. Using humanized mice with human PD-1 xenografts of human PD-L1 knock-in mouse MC38 cancer cells, we demonstrated that YPD-30 exhibited significant antitumor activity and was well tolerated in vivo. Taken together, our results indicate that YPD-30 serves as a promising therapeutic candidate for anti-human PD-L1 cancer immunotherapy.

1 September 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
XDXinyan Dai
Xinyan Dai
KWKe Wang
Ke Wang
HCHao Chen
Hao Chen
XHXupeng Huang
Xupeng Huang
ZFZhiqiang Feng
Zhiqiang Feng

1 April 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YLYongqiang Li
Yongqiang Li
KTKang Tian
Kang Tian
AQAifang Qin
Aifang Qin
LZLijian Zhang
Lijian Zhang
LHLianchao Huo
Lianchao Huo
ZFZhiqiang Feng
Zhiqiang Feng

1 May 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HCHao Chen
Hao Chen
KWKe Wang
Ke Wang
YYYang Yang
Yang Yang
XHXupeng Huang
Xupeng Huang
XDXinyan Dai
Xinyan Dai
ZFZhiqiang Feng
Zhiqiang Feng